Skip to main content

Table 2 The results for GO analysis in MI patients compared to stable CAD ones

From: KLRD1, FOSL2 and LILRB3 as potential biomarkers for plaques progression in acute myocardial infarction and stable coronary artery disease

Gene set

Description

Size

Expect

Ratio

P value

FDR

GO:0036230

Granulocyte activation

500

14.318

4.4002

0

0

GO:0002250

Adaptive immune response

382

10.939

4.0224

2.66E−15

7.55E−13

GO:0045088

Regulation of innate immune response

369

10.566

3.8802

8.45E−14

1.44E−11

GO:0002694

Regulation of leukocyte activation

481

13.773

3.3398

5.88E−13

7.13E−11

GO:0002521

Leukocyte differentiation

496

14.203

3.2387

1.75E−12

1.49E−10

GO:0050727

Regulation of inflammatory response

361

10.337

3.5793

1.65E−11

1.17E−09

GO:0006909

Phagocytosis

238

6.8152

3.9618

1.08E−09

5.73E−08

GO:0002237

Response to molecule of bacterial origin

330

9.4496

3.3864

1.66E−09

7.84E−08

GO:0006968

Cellular defense response

55

1.5749

7.6194

3.74E−08

1.4469E−06

GO:0050900

Leukocyte migration

419

11.998

2.8338

4.69E−08

1.7328E−06

  1. GO, gene-ontology; CAD, coronary artery disease; FDR, false discovery rate